CIK: 1413306 - Address: C/O Corvus Pharmaceuticals, Inc., 863 Mitten Road, Suite 102, Burlingame, CA 94010
8 results

TC

Stat

Stk

Ins

Fil

+d

+w

+m

+q

+h

+y

avg

P%ret11648805-28-0
P%wins67675050602052
S%ret111-2-8-5-31-32-54-22
S%wins100100100100100100100

Filing Date

T Date

Ticker

Issuer

Inc

Sector

Ind

Industry

Owner

oSt

Rel

Title

T

TVal

Price

L

Qty

oc

Own

H

r2y

r1y

r6m

r3m

r6w

r3w

r7d

r3d

f1d

f1w

f1m

f3m

f6m

f1y

5/16/23 16:54
5/15/23
CRVSCorvus Pharmaceuticals, Inc.DEHealthDrugPharmaceutical PreparationsGrais LindaCADP252.45010New10D
12/8/16 16:18
12/7/16
OCRXOcera Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsGrais Linda SCADOP,CEOP152.14171170D-67-31-19-9-13-11-2-5-3-6-4-42
3/7/16 08:08
3/4/16
OCRXOcera Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsGrais Linda SCADOP,CEOP103.1903563D-81-36-18-931131081015-6-21-35-81
1/25/16 17:19
1/22/16
OCRXOcera Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsGrais Linda SCADOP,CEOP242.380102060D-83-62-41-30-24-23-1414-1419189-23
1/19/16 08:14
1/15/16
OCRXOcera Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsGrais Linda SCADOP,CEOP212.080102550D-89-67-54-47-39-41-31-278273844377
5/6/15 18:03
5/6/15
OCRXOcera Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsGrais Linda SCADOP,CEOP1123.7303030040D-41-58-39-43-27-10-85910513-7-21
7/15/14 16:05
7/11/14
OCRXOcera Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsGrais Linda SCADOP,CEOP595.93110New10D-88-4-61-33-15-20-22-173-3-2-1123-20
3/30/10 17:30
3/29/10
ABIOArca Biopharma, Inc.DEHealthDiagnIn Vitro & In Vivo DiagnosticGrais Linda SCADS-1,5557.381-211-30492I-563457819397106116-2-8-5-31-32-54

DDerivative transaction in filing (usually option exercise)
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
AAmended filing
EError detected in filing
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top

Contact